BioSpace News Archive

Littelfuse, Inc. (NASDAQ: LFUS), a global manufacturer of leading technologies in circuit protection, power control and sensing, announced today that it will release financial results for its third quarter of fiscal 2020 prior to market open on Wednesday, October 28, 2020.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement today:

The Medical Device Innovation Consortium (MDIC) announced today that the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) will participate in its Case for Quality Collaborative Community (CfQcc) initiative.

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Professor Emmanuelle Charpentier, congratulates Emmanuelle on being awarded the 2020 Nobel Prize in Chemistry for her groundbreaking work on the CRISPR-Cas9 system.

Streamlined solution features quality control reagent kits, robotic sample preparation, mass spectrometry analysis and data reporting software to transform analysis efficiency WALTHAM, Mass.--( BUSINESS WIRE )-- PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today launched the cannabis industry’s first fully-automated liquid handling sample preparation and LC/MS/MS analysis workflow for pesticide residue testing

AIMS is an artificially intelligent prototype system, built and developed with clinicians in a clinical environment, that explores the potential of using AI and computer vision to prevent the spread of hospital acquired infections (HAIs) caused by inadequate hand hygiene. - By leveraging specially trained neural networks to monitor compliance with hand hygiene policies, AIM

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company pioneering targeted C3 therapies, announced that the company approved the grant of equity awards to four new employees with grant date of October 1, 2020, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan and material to the employees’ acceptance of employment with the company.

Axonics ® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year ® 2020 Award Winner for Orange County

Scientists at Diomics Corp. will be seeking an accelerated regulatory pathway for a version of the company’s previously announced prophylactic monoclonal antibody nasal spray, Dioguard™, which they believe holds promise both to protect against coronavirus infection and to prevent asymptomatic carriers from unknowingly spreading the infection to others.

Today, Jennifer Doudna, Ph.D., one of Intellia Therapeutics, Inc.’s scientific co-founders, was awarded the 2020 Nobel Prize in Chemistry for the development of the CRISPR/Cas9 genome editing technology. Dr. Doudna shared the award with her research collaborator, Dr. Emmanuelle Charpentier. This is the first time two women scientists have jointly won a Nobel Prize in Chemistry. Since the publication of the seminal 2012 Science paper, Dr.